Retatrutide is a new treatment in the fight against obesity. This groundbreaking drug, classified as a dual GLP-1 and GIP receptor agonist, shows promising results in clinical trials. By boosting these receptors, https://sabrinapuie293704.ka-blogs.com/89462089/setmelanotide-a-promising-new-treatment-for-obesity